IMPACT OF MIRABEGRON TREATMENT AND SYMPTOM SEVERITY ON WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH OVERACTIVE BLADDER

被引：1
|
作者：
De, G. [1 ]
Yang, H. [2 ]
Runken, M. C. [3 ]
Yan, Y. [1 ]
Kelkar, S. [1 ]
Bui, C. N. [3 ]
Xie, J. [1 ]
Wu, E. Q. [2 ]
机构：
[1] Anal Grp Inc, New York, NY USA
[2] Anal Grp Inc, Boston, MA USA
[3] Astellas Pharma US Inc, Northbrook, IL USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.923
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A183 / A184
页数：2
相关论文
共 50 条
  • [31] THE USE OF MIRABEGRON IN THE TREATMENT OF OVERACTIVE BLADDER IN PATIENTS AFFECTED BY PARKINSON'S DISEASE
    Gubbiotti, Marilena
    de Vermandois, Jacopo Adolfo Rossi
    Turco, Morena
    Salvini, Eleonora
    Cagini, Roberta
    Giannantoni, Antonella
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S82 - S83
  • [32] Combined treatment of solifenacin and mirabegron, an alternative in patients with overactive bladder (BESIDE study)
    Alcantara-Montero, A.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (09): : 593 - 594
  • [33] Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder
    Nitti, Victor W.
    Rovner, Eric S.
    Franks, Billy
    Muma, Gilbert N.
    Berner, Todd
    Fan, Alan
    Ng, Daniel B.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (02)
  • [34] Transdermal oxybutynin with an educational intervention for overactive bladder -: Impact on work productivity
    Sand, Peter K.
    Pizzi, Laura T.
    Dahl, Naomi V.
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 126S - 126S
  • [35] The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
    Gubbiotti, Marilena
    Giannantoni, Antonella
    Cantaluppi, Simona
    Coluccia, Anna Chiara
    Ghezzi, Fabio
    Serati, Maurizio
    BMC UROLOGY, 2019, 19 (1)
  • [36] The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
    Marilena Gubbiotti
    Antonella Giannantoni
    Simona Cantaluppi
    Anna Chiara Coluccia
    Fabio Ghezzi
    Maurizio Serati
    BMC Urology, 19
  • [37] Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder Results from the MATRIX Study
    Pizzi, Laura T.
    Talati, Amy
    Gemmen, Eric
    Dahl, Naomi V.
    Bunz, Thomas J.
    Sand, Peter K.
    PHARMACOECONOMICS, 2009, 27 (04) : 329 - 339
  • [38] Strong Correlation Between the Overactive Bladder Symptom Score and Urgency Severity Score in Assessment of Patients With Overactive Bladder Syndrome
    Ke, Qian-Sheng
    Kuo, Hann-Chorng
    TZU CHI MEDICAL JOURNAL, 2010, 22 (02): : 82 - 86
  • [39] Impact of gender on work productivity loss and activity impairment in asthmatic patients
    Braham, Y.
    Touil, I.
    Hamdi, A.
    Ayeb, J.
    Omrane, A.
    Rhomdhani, R.
    Bouchareb, S.
    Boujneh, S.
    Zaara, E.
    Khalfallah, T.
    Boussoffara, L.
    Kneni, J.
    Boudawwara, N.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [40] Higher urge severity score predicts resumption of overactive bladder (OAB) medication following discontinuation of mirabegron treatment in patients with OAB
    Wang, Chung-Cheng
    Jiang, Yung-Hong
    Kuo, Hann-Chorng
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (02) : O180 - O185
12345